PAULA WIBOWO: Open Payments
NPI 1427681410 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,265 in 112 payments from 16 companies in 2025. Trend: 2023 $1,803 · 2024 $2,092 · 2025 $2,265
Food & beverage: $2,265
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $507 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $279 |
| Phathom Pharmaceuticals, Inc. | 10 | $223 |
| Gilead Sciences, Inc. | 7 | $197 |
| Ipsen Biopharmaceuticals, Inc | 7 | $195 |
| PFIZER INC. | 10 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $148 |
| Ardelyx, Inc. | 6 | $129 |
| Mallinckrodt Hospital Products Inc. | 3 | $78 |
| Aimmune Therapeutics, Inc. | 4 | $75 |
Products named: XIFAXAN, VOQUEZNA, RINVOQ, IQIRVO, CREON, IBSRELA, ENTYVIO, XELJANZ.
Industry payments across FL — which companies pay providers there.
